To read more on this topic click here.
Genetic database gives hope for potential Parkinson’s treatment
News
Author: Saskia MairPublished: 4 June 2020
Prep:
Cook:
Serves:
The Genome Aggregation Database (gnomAD) – the world’s largest public database of variations in DNA which can cause diseases – has given scientists hope for a potential Parkinson’s treatment.
UK and US researchers from Imperial College London, the Broad Institute of MIT and Harvard, 23andMe and the Michael J. Fox Foundation used gnomAD to study variants in the LRRK2 gene, which increases the risk of Parkinson’s. Previous studies have shown that blocking the protein formed by the gene can lead to organ damage in animals – but the scientists now suggest this approach should be safe for humans.
Research fellow Dr Nicky Whiffin said: “Large genetic databases are increasingly giving us a powerful insight into the likely impact of certain drugs. If we see that genetic variants that naturally reduce the amount of protein in our body do not result in severe diseases, we can be more confident that targeting that protein therapeutically will also be safe.”
For more information on the latest Parkinson’s research please visit the EPDA website.
Read more:
Diesel exhaust fumes may increase the risk of Parkinson’s, study suggests
Can Covid-19 increase the risk of developing Parkinson’s?
Last Month
Next Month
Share this story
Related articles
Perspectives
Janet Reno “showed the world that Parkinson’s does not have to define you”
Tributes paid to Janet Reno, first female US Attorney General
READ MORE
Interviews
Swimming the English Channel for Parkinson’s
From England to France without a wetsuit
READ MORE
PD in Practice
6 tips for improving speech in Parkinson’s
How to get the most from speech therapy sessions with PwPs
READ MORE
Comments